drugset / Trial / NCT01521949

Study of Acai Juice in Asymptomatic or Minimally Symptomatic Prostate Cancer Patients With Rising PSA

NCT01521949 ↗

Phase 2 Completed 21 enrolled University of Colorado, Denver
NaSingle-groupOpen-labelTreatment

Summary

Men who have Prostate Specific Antigen (PSA) recurrence with low PSA levels and long doubling times do not require immediate treatment with androgen deprivation therapy and may be safely observed. In these situations where current treatment options may cause more unnecessary side effects than anticipated benefit, it is reasonable to use a low-risk natural product such as Acai Juice Product with antioxidant properties to evaluate whether there are any anti-cancer effects.

Timeline

Start
2011-11-04
Primary completion
2013-12-25
Completion
2018-02-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Acai Juice Product Unknown 2 unknown Oral

Indications